Cell line · CVCL_0363
Papers42
1 to 20 of 42
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Molecular mechanisms underlying the effectiveness of triiodothyroacetic acid (Triac) in patients with resistance to thyroid hormone β (RTHβ): a multicentre, international, retrospective cohort study. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A fully human pan VL9 HLA-E TCRm antibody enables functional dissection of HLA-E biology and checkpoint signaling. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SR-B1-Mediated Transplacental Transfer of Hydrophobic Toxicants Disrupts Fetal Development During Barriergenesis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Selective Targeting of Immune Checkpoints HLA-G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer Immunity. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HRS Degradation-Induced Nicotinamide Deficiency in Placental Extracellular Vesicles Triggers Preeclampsia by Disrupting Maternal-Fetal Immune Homeostasis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TP53BP2 Promotes Placental Autophagy and Preeclampsia via G9a and DNMT1 Cooperatively Modulating E2F1. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Atosiban-conjugated 3WJ-pRNA nanoparticles delivering GAS1-enhanced extracellular vesicles: targeting the decidua to combat recurrent miscarriage. | J Nanobiotechnology | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A triple-action PROTAC for wild-type p53 cancer therapy. | Cell Rep Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Extracellular Hsp70 and Circulating Endometriotic Cells as Novel Biomarkers for Endometriosis. | Int J Mol Sci | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG. | Mol Med Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Fibronectin and JMJD6 Signature in Circulating Placental Extracellular Vesicles for the Detection of Preeclampsia. | Endocrinology | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Molecular characteristics of established trophoblast-derived cell lines. | Placenta | 2021 | Cellosaurus cites it | PubMed | |
| TMEM41B Is a Pan-flavivirus Host Factor. | Cell | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Clinical and Functional Consequences of C-Terminal Variants in MCT8: A Case Series. | J Clin Endocrinol Metab | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Cytogenomics of six human trophoblastic cell lines. | Placenta | 2021 | Cellosaurus cites it | PubMed | |
| Insights Into the Mechanism of MCT8 Oligomerization. | J Endocr Soc | 2020 | Its Methods give the RRID and name the line | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0363/papers